Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk

References

• Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue. J Clin Apher. 2019;34(3):1–11.
   Web of Science ®Google Scholar
• Abe T, Matsuo H, Abe R, et al. The Japanese society for apheresis clinical practice guideline for therapeutic apheresis. Ther Apher Dial. 2021;25(6):728–876.
   PubMed Web of Science ®Google Scholar
• Chen YY, Sun X, Huang W, et al. Therapeutic apheresis in kidney diseases: an updated review. Ren Fail. 2022;44(1):842–857.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Kaplan A. Therapeutic plasma exchange using membrane plasma separation. Clin J Am Soc Nephrol. 2020;15(9):1364–1370.
   PubMed Web of Science ®Google Scholar
• Bowry SK, Kircelli F, Himmele R, et al. Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation. Clin Kidney J. 2021;14(Suppl 4):i59–i71.
   PubMedGoogle Scholar
• Retter A, Barrett NA. The management of abnormal haemostasis in the ICU. Anaesthesia. 2015;70 Suppl 1(Suppl 1):121–127. e40–1.
   PubMedGoogle Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84.
   PubMedGoogle Scholar
• Brunetta Gavranić B, Bašić-Jukić N, Premužić V, et al. Membrane therapeutic plasma exchange with and without heparin anticoagulation. J Clin Apher. 2017;32(6):479–485.
   PubMed Web of Science ®Google Scholar
• Gashti CN, Andreoli DC, Patel D. Membrane-based therapeutic plasma exchange (mTPE): technical and clinical experience. J Clin Apher. 2018;33(1):38–45.
   PubMed Web of Science ®Google Scholar
• Yuan F, Li Z, Li X, et al. Application of regional citrate anticoagulation in membrane therapeutic plasma exchange. Int Urol Nephrol. 2020;52(12):2379–2384.
   PubMed Web of Science ®Google Scholar
• Beurskens DMH, Huckriede JP, Schrijver R, et al. The anticoagulant and nonanticoagulant properties of heparin. Thromb Haemost. 2020;120(10):1371–1383.
   PubMed Web of Science ®Google Scholar
• Bauer PR, Ostermann M, Russell L, et al. Plasma exchange in the intensive care unit: a narrative review. Intensive Care Med. 2022;48(10):1382–1396.
   PubMed Web of Science ®Google Scholar
• van de Wetering J, Westendorp RG, van der Hoeven JG, et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol. 1996;7(1):145–150.
   PubMed Web of Science ®Google Scholar
• Syed S, Reilly RF. Heparin-induced thrombocytopenia: a renal perspective. Nat Rev Nephrol. 2009;5(9):501–511.
   PubMed Web of Science ®Google Scholar
• Yuan S, Qian Y, Tan D, et al. Therapeutic plasma exchange: a prospective randomized trial to evaluate 2 strategies in patients with liver failure. Transfus Apher Sci. 2018;57(2):253–258.
   PubMed Web of Science ®Google Scholar
• Bai M, Zhou M, He L, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098–2110.
   PubMed Web of Science ®Google Scholar
• Kindgen-Milles D, Brandenburger T, Dimski T. Regional citrate anticoagulation for continuous renal replacement therapy. Curr Opin Crit Care. 2018;24(6):450–454.
   PubMed Web of Science ®Google Scholar
• Tolwani A, Wille KM. Advances in continuous renal replacement therapy: citrate anticoagulation update. Blood Purif. 2012;34(2):88–93.
   PubMed Web of Science ®Google Scholar
• Monchi M. Citrate pathophysiology and metabolism. Transfus Apher Sci. 2017;56(1):28–30.
   PubMed Web of Science ®Google Scholar
• Kramer L, Bauer E, Joukhadar C, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med. 2003;31(10):2450–2455.
   PubMed Web of Science ®Google Scholar
• Bauer E, Derfler K, Joukhadar C, et al. Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis. 2005;46(5):903–907.
   PubMed Web of Science ®Google Scholar
• Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649–672.
   PubMed Web of Science ®Google Scholar
• Zhang W, Bai M, Yu Y, et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care. 2019;23(1):22.
   PubMedGoogle Scholar
• Mei CL, Ye CY, Rong S. A practical handbook for dialysis. 2nd ed. Beijing: People’s Medical Publishing House; 2009. p. 53–115.
   Google Scholar
• Singer RF, Williams O, Mercado C, et al. Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care. Can J Kidney Health Dis. 2016;3:22.
   PubMedGoogle Scholar
• Cheng YL, Yu AW, Tsang KY, et al. Anticoagulation during haemodialysis using a citrate-enriched dialysate: a feasibility study. Nephrol Dial Transplant. 2011;26(2):641–646.
   PubMed Web of Science ®Google Scholar
• Wright S, Steinwandel U, Ferrari P. Citrate anticoagulation using ACD solution a during long-term haemodialysis. Nephrology. 2011;16(4):396–402.
   PubMed Web of Science ®Google Scholar
• Khadzhynov D, Schelter C, Lieker I, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29(2):265–271.
   PubMed Web of Science ®Google Scholar
• Pepe J, Colangelo L, Biamonte F, et al. Diagnosis and management of hypocalcemia. Endocrine. 2020;69(3):485–495.
   PubMed Web of Science ®Google Scholar
• Rhee H, Berenger B, Mehta RL, et al. Regional citrate anticoagulation for continuous kidney replacement therapy with calcium-containing solutions: a cohort study. Am J Kidney Dis. 2021;78(4):550–559.e1.
   PubMed Web of Science ®Google Scholar
• Morgera S, Schneider M, Slowinski T, et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med. 2009;37(6):2018–2024.
   PubMed Web of Science ®Google Scholar
• Ma Y, Chen F, Xu Y, et al. Safety and efficacy of regional citrate anticoagulation during plasma adsorption plus plasma exchange therapy for patients with acute-on-chronic liver failure: a pilot study. Blood Purif. 2019;48(3):223–232.
   PubMed Web of Science ®Google Scholar
• Peng X, Xie X, Yin J, et al. Anticoagulation effect and safety observation of regional citrate anticoagulation for double-filtration plasmapheresis in critical patients. Blood Purif. 2020;49(5):542–549.
   PubMed Web of Science ®Google Scholar
• Betjes MG, van Oosterom D, van Agteren M, et al. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol. 2007;20(5):602–608. PMID: 17918147.
   PubMed Web of Science ®Google Scholar
• MacEwen C, Watkinson P, Winearls C. Circuit life versus bleeding risk: the impact of achieved activated partial thromboplastin time versus achieved filtration fraction. Ther Apher Dial. 2015;19(3):259–266.
   PubMed Web of Science ®Google Scholar
• Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369(26):2525–2534.
   PubMed Web of Science ®Google Scholar
• van der Meulen J, Janssen MF, Oe PL. Cardiac arrest during rapid plasma exchange for haemolytic uraemic syndrome. Nephrol Dial Transplant. 1994;9:1841. PMID: 7708283.
   PubMed Web of Science ®Google Scholar
• Pearl RG, Rosenthal MH. Metabolic alkalosis due to plasmapheresis. Am J Med. 1985;79(3):391–393.
   PubMed Web of Science ®Google Scholar
• Cid J, Carbassé G, Gamir M, et al. Acid-base balance disturbances in plasma exchange depend on the replacement fluid used. Transfusion. 2015;55(11):2653–2658.
   PubMed Web of Science ®Google Scholar
• Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014;371(15):1434–1445.
   PubMed Web of Science ®Google Scholar
• Schneider AG, Journois D, Rimmelé T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care. 2017;21(1):281.
   PubMedGoogle Scholar
• Choi MY, Lee JD, Lee SH, et al. Metabolic alkalosis induced by plasmapheresis in a patient with systemic lupus erythematosus. J Korean Med Sci. 1993;8(3):207–209.
   PubMedGoogle Scholar
• Nagai Y, Itabashi M, Mizutani M, et al. A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura. Ther Apher Dial. 2008;12(1):86–90.
   PubMed Web of Science ®Google Scholar
• Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Crit Care. 2012;16(6):249.
   PubMed Web of Science ®Google Scholar